AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $648 | -4.4% | 9,267 | -1.8% | 0.00% | -20.0% |
Q2 2023 | $678 | +9.5% | 9,437 | -5.9% | 0.01% | +25.0% |
Q1 2023 | $619 | +138.1% | 10,033 | +198.2% | 0.00% | +100.0% |
Q4 2022 | $260 | -99.9% | 3,365 | -34.1% | 0.00% | +100.0% |
Q1 2022 | $211,000 | -14.6% | 5,104 | +39.6% | 0.00% | 0.0% |
Q2 2021 | $247,000 | +19.3% | 3,655 | +44.1% | 0.00% | 0.0% |
Q4 2020 | $207,000 | – | 2,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |